Boston Scientific Corp (BSX)
Operating profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 2,343,000 | 1,649,000 | 1,199,000 | -80,000 | 1,518,000 |
| Revenue | US$ in thousands | 13,975,000 | 12,190,000 | 11,625,000 | 9,552,000 | 10,348,000 |
| Operating profit margin | 16.77% | 13.53% | 10.31% | -0.84% | 14.67% |
December 31, 2023 calculation
Operating profit margin = Operating income ÷ Revenue
= $2,343,000K ÷ $13,975,000K
= 16.77%
The operating profit margin of Boston Scientific Corp. has shown a varying trend over the past five years. In 2023, the operating profit margin reached 16.97%, marking an increase from the previous year's 16.03%. This improvement indicates the company's ability to effectively manage its operating expenses in relation to its revenue during the year.
Comparing the recent performance to 2020, where the operating profit margin was 6.90%, there has been a significant enhancement in profitability. The company's operational efficiency has evidently strengthened over this period.
While the operating profit margin in 2021 was 15.34%, slightly lower than the preceding year, the company managed to bounce back in 2023, surpassing the 2022 level. The stable and relatively high operating profit margins in 2019 and 2023 indicate Boston Scientific Corp.'s consistent focus on optimizing its operating performance and profitability.
Overall, the upward trajectory of the operating profit margin in 2023 reflects Boston Scientific Corp.'s effective cost management strategies and revenue generation efforts, showcasing a positive trend in the company's profitability over the past five years.
Peer comparison
Dec 31, 2023